These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 28276481)
1. Identification of berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies. Wang X; Zhang Y; Yang Y; Wu X; Fan H; Qiao Y Sci Rep; 2017 Mar; 7():44040. PubMed ID: 28276481 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of berberine as a natural fungicide: biodegradation and antimicrobial mechanism. Li Y; Yin YM; Wang XY; Wu H; Ge XZ J Asian Nat Prod Res; 2018 Feb; 20(2):148-162. PubMed ID: 28534425 [TBL] [Abstract][Full Text] [Related]
3. Computational and experimental prediction of molecules involved in the anti-melanoma action of berberine. Liu B; Fu XQ; Li T; Su T; Guo H; Zhu PL; Tse AK; Liu SM; Yu ZL J Ethnopharmacol; 2017 Aug; 208():225-235. PubMed ID: 28729227 [TBL] [Abstract][Full Text] [Related]
4. Expression of the TetA gene encoding TetA efflux protein in E. coli contributes to its increased bacterial resistance toward berberine. Li Y; Cao ZT; Wang XY; Ge XZ J Asian Nat Prod Res; 2018 Apr; 20(4):374-384. PubMed ID: 28956622 [TBL] [Abstract][Full Text] [Related]
5. Berberine Directly Targets the NEK7 Protein to Block the NEK7-NLRP3 Interaction and Exert Anti-inflammatory Activity. Zeng Q; Deng H; Li Y; Fan T; Liu Y; Tang S; Wei W; Liu X; Guo X; Jiang J; Wang Y; Song D J Med Chem; 2021 Jan; 64(1):768-781. PubMed ID: 33440945 [TBL] [Abstract][Full Text] [Related]
6. Functional and binding studies of gallic acid showing platelet aggregation inhibitory effect as a thrombin inhibitor. Zhang Y; Wang X; Lu B; Gao Y; Zhang Y; Li Y; Niu H; Fan L; Pang Z; Qiao Y Chin Herb Med; 2022 Apr; 14(2):303-309. PubMed ID: 36117662 [TBL] [Abstract][Full Text] [Related]
7. Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity. Paul M; Hemshekhar M; Kemparaju K; Girish KS Free Radic Biol Med; 2019 Jan; 130():196-205. PubMed ID: 30391673 [TBL] [Abstract][Full Text] [Related]
8. Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment. Jabbarzadeh Kaboli P; Ismail P; Ling KH PLoS One; 2018; 13(3):e0193941. PubMed ID: 29565994 [TBL] [Abstract][Full Text] [Related]
9. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin. Wong PC; Jiang X Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316 [TBL] [Abstract][Full Text] [Related]
10. The natural product berberine is a human prolyl oligopeptidase inhibitor. Tarrago T; Kichik N; SeguĂ J; Giralt E ChemMedChem; 2007 Mar; 2(3):354-9. PubMed ID: 17295371 [TBL] [Abstract][Full Text] [Related]
11. Effect of low and high dose melagatran and other antithrombotic drugs on platelet aggregation. Soslau G; Ando A; Floyd L; Hong T; Mathew L; Yen Y J Thromb Thrombolysis; 2008 Apr; 25(2):198-203. PubMed ID: 17710375 [TBL] [Abstract][Full Text] [Related]
12. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action. Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791 [TBL] [Abstract][Full Text] [Related]
13. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors. Puri RN; Colman RW Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848 [TBL] [Abstract][Full Text] [Related]
15. Preparation, pharmacokinetics and tumour-suppressive activity of berberine liposomes. Wang X; Wang Q; Liu Z; Zheng X J Pharm Pharmacol; 2017 Jun; 69(6):625-632. PubMed ID: 28295319 [TBL] [Abstract][Full Text] [Related]
16. Berberine induces dedifferentiation by actin cytoskeleton reorganization via phosphoinositide 3-kinase/Akt and p38 kinase pathways in rabbit articular chondrocytes. Yu SM; Cho H; Kim GH; Chung KW; Seo SY; Kim SJ Exp Biol Med (Maywood); 2016 Apr; 241(8):800-7. PubMed ID: 26851252 [TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors. Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181 [TBL] [Abstract][Full Text] [Related]
18. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Wu X; Li Q; Xin H; Yu A; Zhong M Eur J Clin Pharmacol; 2005 Sep; 61(8):567-72. PubMed ID: 16133554 [TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effects of berberine on acetaminophen-induced hepatotoxicity in mice. Zhao Z; Wei Q; Hua W; Liu Y; Liu X; Zhu Y Biomed Pharmacother; 2018 Jul; 103():1319-1326. PubMed ID: 29864914 [TBL] [Abstract][Full Text] [Related]
20. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]